These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25908420)
21. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases]. Zhu C; Zhao YB; Kong LF; Li ZH; Kang J Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611 [TBL] [Abstract][Full Text] [Related]
22. Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases. Ohkouchi S; Akasaka K; Ichiwata T; Hisata S; Iijima H; Takada T; Tsukada H; Nakayama H; Machiya JI; Irokawa T; Ogawa H; Shibata Y; Ichinose M; Ebina M; Nukiwa T; Kurosawa H; Nakata K; Tazawa R Ann Am Thorac Soc; 2017 Aug; 14(8):1298-1304. PubMed ID: 28421817 [TBL] [Abstract][Full Text] [Related]
23. Serum KL-6 in pulmonary alveolar proteinosis: China compared historically with Germany and Japan. Guo WL; Zhou ZQ; Chen L; Su ZQ; Zhong CH; Chen Y; Li SY J Thorac Dis; 2017 Feb; 9(2):287-295. PubMed ID: 28275476 [TBL] [Abstract][Full Text] [Related]
24. A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Yamamoto H; Yamaguchi E; Agata H; Kandatsu N; Komatsu T; Kawai S; Baba K; Awaya T; Nishikomori R; Tsurusawa M; Nakata K Pediatr Pulmonol; 2008 Aug; 43(8):828-30. PubMed ID: 18618617 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary alveolar proteinosis during a 30-year observation. Diagnosis and treatment. Fijołek J; Wiatr E; Radzikowska E; Bestry I; Langfort R; Polubiec-Kownacka M; Prokopowicz J; Roszkowski-Śliż K Pneumonol Alergol Pol; 2014; 82(3):206-17. PubMed ID: 24793148 [TBL] [Abstract][Full Text] [Related]
26. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401 [TBL] [Abstract][Full Text] [Related]
27. Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis. Akasaka K; Amano M; Nakamura T; Nishizawa T; Yamakawa H; Sato S; Aoki A; Shima K; Matsushima H; Takada T Respir Investig; 2024 Jul; 62(4):610-616. PubMed ID: 38705133 [TBL] [Abstract][Full Text] [Related]
28. Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report. Sato S; Akasaka K; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Kusano K; Oba T; Nishizawa T; Kawabe R; Yamakawa H; Amano M; Matsushima H; Takada T BMC Pulm Med; 2020 Apr; 20(1):84. PubMed ID: 32252718 [TBL] [Abstract][Full Text] [Related]
29. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis. Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784 [TBL] [Abstract][Full Text] [Related]
31. Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis. Ishikawa N; Kondo K; Oguri T; Kamitsuna M; Sakurai J; Fujitaka K; Yamasaki M; Maeda H; Isobe T; Kohno N Intern Med; 2002 May; 41(5):381-5. PubMed ID: 12058888 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary alveolar proteinosis: an overview for internists and hospital physicians. Das M; Salzman GA Hosp Pract (1995); 2010 Feb; 38(1):43-9. PubMed ID: 20469623 [TBL] [Abstract][Full Text] [Related]
33. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis. Kobayashi M; Takeuchi T; Ohtsuki Y Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary Alveolar Proteinosis Syndrome. Kelly A; McCarthy C Semin Respir Crit Care Med; 2020 Apr; 41(2):288-298. PubMed ID: 32279299 [TBL] [Abstract][Full Text] [Related]
35. [Effectiveness and safety of inhaled granulocyte-macrophage colony-stimulating factor therapy in idiopathic pulmonary alveolar proteinosis]. Ding J; Xiao Y; Dai J; Miao L; Qiu Y; Chen L; Jiang H; Cai H Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2766-70. PubMed ID: 26711974 [TBL] [Abstract][Full Text] [Related]